
Revolutionizing MS Treatment: ENHANCE Study Shows Promising Results for BRIUMVI Infusions in Just 30 Minutes
Exciting Updates from TG Therapeutics, Inc. at ECTRIMS 2024 Infusion Related Reactions with BRIUMVI Recently presented data from the ENHANCE Phase 3b trial by TG Therapeutics, Inc. showcased the mild (Grade 1) infusion-related reactions experienced by patients receiving 30-minute BRIUMVI infusions. These reactions were found to resolve completely, highlighting the safety profile of this treatment….